463 related articles for article (PubMed ID: 16728551)
21. Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.
Bhasin S; Parker RA; Sattler F; Haubrich R; Alston B; Umbleja T; Shikuma CM;
J Clin Endocrinol Metab; 2007 Mar; 92(3):1049-57. PubMed ID: 17164307
[TBL] [Abstract][Full Text] [Related]
22. The role of androgen receptor CAG repeat polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes: TIMES2 sub-study.
Stanworth RD; Akhtar S; Channer KS; Jones TH
Eur J Endocrinol; 2014 Feb; 170(2):193-200. PubMed ID: 24165020
[TBL] [Abstract][Full Text] [Related]
23. [Testosterone replacement in hypogonadotropic hypogonadal young male improves insulin sensitivity].
Mao JF; Wu XY; Li NS; Lu SY; Jing ZM; Shi YF
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2550-2. PubMed ID: 19080648
[TBL] [Abstract][Full Text] [Related]
24. Effect of testosterone on insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism.
Naharci MI; Pinar M; Bolu E; Olgun A
Endocr Pract; 2007 Oct; 13(6):629-35. PubMed ID: 17954419
[TBL] [Abstract][Full Text] [Related]
25. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
[TBL] [Abstract][Full Text] [Related]
26. Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study.
Haider A; Yassin A; Haider KS; Doros G; Saad F; Rosano GM
Vasc Health Risk Manag; 2016; 12():251-61. PubMed ID: 27366080
[TBL] [Abstract][Full Text] [Related]
27. Effect of testosterone replacement therapy on insulin sensitivity and body composition in congenital hypogonadism: A prospective longitudinal follow-up study.
Reddy KC; Yadav SB
J Postgrad Med; 2021; 67(2):67-74. PubMed ID: 33942770
[TBL] [Abstract][Full Text] [Related]
28. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
[TBL] [Abstract][Full Text] [Related]
29. The effect of testosterone on insulin sensitivity in men with heart failure.
Malkin CJ; Jones TH; Channer KS
Eur J Heart Fail; 2007 Jan; 9(1):44-50. PubMed ID: 16828341
[TBL] [Abstract][Full Text] [Related]
30. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.
Malkin CJ; Pugh PJ; Morris PD; Kerry KE; Jones RD; Jones TH; Channer KS
Heart; 2004 Aug; 90(8):871-6. PubMed ID: 15253956
[TBL] [Abstract][Full Text] [Related]
31. Testosterone therapy has positive effects on anthropometric measures, metabolic syndrome components (obesity, lipid profile, Diabetes Mellitus control), blood indices, liver enzymes, and prostate health indicators in elderly hypogonadal men.
Canguven O; Talib RA; El Ansari W; Yassin DJ; Salman M; Al-Ansari A
Andrologia; 2017 Dec; 49(10):. PubMed ID: 28295504
[TBL] [Abstract][Full Text] [Related]
32. Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus - a series of case reports.
Saad F; Yassin A; Almehmadi Y; Doros G; Gooren L
Aging Male; 2015; 18(3):164-8. PubMed ID: 26075537
[TBL] [Abstract][Full Text] [Related]
33. Metabolic syndrome and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism.
Sonmez A; Haymana C; Bolu E; Aydogdu A; Tapan S; Serdar M; Altun B; Barcin C; Taslipinar A; Meric C; Uckaya G; Kutlu M
Eur J Endocrinol; 2011 May; 164(5):759-64. PubMed ID: 21325471
[TBL] [Abstract][Full Text] [Related]
34. Male hypogonadism and metabolic syndrome.
Naifar M; Rekik N; Messedi M; Chaabouni K; Lahiani A; Turki M; Abid M; Ayedi F; Jamoussi K
Andrologia; 2015 Jun; 47(5):579-86. PubMed ID: 25040289
[TBL] [Abstract][Full Text] [Related]
35. Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy.
Dimitriadis GK; Randeva HS; Aftab S; Ali A; Hattersley JG; Pandey S; Grammatopoulos DK; Valsamakis G; Mastorakos G; Jones TH; Barber TM
Endocrine; 2018 Apr; 60(1):175-184. PubMed ID: 29396841
[TBL] [Abstract][Full Text] [Related]
36. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
Yassin DJ; Doros G; Hammerer PG; Yassin AA
J Sex Med; 2014 Jun; 11(6):1567-76. PubMed ID: 24712761
[TBL] [Abstract][Full Text] [Related]
37. Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.
Hackett G
Sex Med Rev; 2019 Jul; 7(3):476-490. PubMed ID: 30803918
[TBL] [Abstract][Full Text] [Related]
38. Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial.
Khripun I; Vorobyev S; Belousov I; Kogan M; Zitzmann M
Aging Male; 2019 Dec; 22(4):241-249. PubMed ID: 30235049
[TBL] [Abstract][Full Text] [Related]
39. Testosterone Therapy and Glucose Homeostasis in Men with Testosterone Deficiency (Hypogonadism).
Saad F
Adv Exp Med Biol; 2017; 1043():527-558. PubMed ID: 29224109
[TBL] [Abstract][Full Text] [Related]
40. Testosterone therapy in diabetes and pre-diabetes.
Corona G; Vena W; Pizzocaro A; Vignozzi L; Sforza A; Maggi M
Andrology; 2023 Feb; 11(2):204-214. PubMed ID: 36542412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]